Lancet Global Health, ISSN 2214-109X, 2015, Volume 3, Issue 9, pp. e564 - e575
Summary Background Most studies of the causes of diarrhoea in low-income and middle-income countries have looked at severe disease in people presenting for...
Internal Medicine | MALNUTRITION | ETIOLOGY | SITE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CHILDHOOD DIARRHEA | ATTRIBUTABLE RISK | DISEASE | GROWTH | GLOBAL ENTERIC MULTICENTER | INFECTION | CHILDREN | Africa - epidemiology | Developing Countries - statistics & numerical data | Humans | Child, Preschool | Diarrhea - epidemiology | Infant | Male | Incidence | Feces - microbiology | Asia - epidemiology | Bacteria - isolation & purification | Diarrhea - microbiology | South America - epidemiology | Bacterial Infections - epidemiology | Polymerase Chain Reaction | Female | Bacterial Infections - microbiology | Infant, Newborn | Cohort Studies
Internal Medicine | MALNUTRITION | ETIOLOGY | SITE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CHILDHOOD DIARRHEA | ATTRIBUTABLE RISK | DISEASE | GROWTH | GLOBAL ENTERIC MULTICENTER | INFECTION | CHILDREN | Africa - epidemiology | Developing Countries - statistics & numerical data | Humans | Child, Preschool | Diarrhea - epidemiology | Infant | Male | Incidence | Feces - microbiology | Asia - epidemiology | Bacteria - isolation & purification | Diarrhea - microbiology | South America - epidemiology | Bacterial Infections - epidemiology | Polymerase Chain Reaction | Female | Bacterial Infections - microbiology | Infant, Newborn | Cohort Studies
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 8, pp. 905 - 914
Summary Background Oral poliovirus vaccine is less immunogenic and effective in low-income countries than in high-income countries, similarly to other oral...
Infectious Disease | RESPONSES | INFECTIOUS DISEASES | ANTIBIOTICS | MULTICENTER | METAANALYSIS | GROWTH | DISEASE | MONOVALENT | ENVIRONMENTAL ENTEROPATHY | DEVELOPING-COUNTRIES | CHILDREN | Immunogenicity, Vaccine | Poliovirus Vaccine, Oral - immunology | Double-Blind Method | Humans | Infant | Poliomyelitis - prevention & control | Poliovirus Vaccine, Oral - administration & dosage | Antibodies, Viral - blood | India | Anti-Bacterial Agents - therapeutic use | Vaccination - methods | Azithromycin - therapeutic use | Poliovirus - immunology | Immunization Schedule | Clinical trials | Medical colleges | Infants | Vaccines | Epidemiology | Communicable diseases | Low income groups | Studies | Pathogens | Antibiotics | Biomarkers | Viruses | Infections | Permeability | Viral infections
Infectious Disease | RESPONSES | INFECTIOUS DISEASES | ANTIBIOTICS | MULTICENTER | METAANALYSIS | GROWTH | DISEASE | MONOVALENT | ENVIRONMENTAL ENTEROPATHY | DEVELOPING-COUNTRIES | CHILDREN | Immunogenicity, Vaccine | Poliovirus Vaccine, Oral - immunology | Double-Blind Method | Humans | Infant | Poliomyelitis - prevention & control | Poliovirus Vaccine, Oral - administration & dosage | Antibodies, Viral - blood | India | Anti-Bacterial Agents - therapeutic use | Vaccination - methods | Azithromycin - therapeutic use | Poliovirus - immunology | Immunization Schedule | Clinical trials | Medical colleges | Infants | Vaccines | Epidemiology | Communicable diseases | Low income groups | Studies | Pathogens | Antibiotics | Biomarkers | Viruses | Infections | Permeability | Viral infections
Journal Article
Vaccine, ISSN 0264-410X, 07/2019, Volume 37, Issue 31, pp. 4407 - 4413
ROTAVAC® (nHRV), derived naturally from the human 116E rotavirus (RV) neonatal strain, was licensed in India in 2015 based on promising results of a phase 3,...
ROTAVAC | Immunogenicity | Rotavirus vaccine | Oral vaccine | Diarrhoea | RV1 | nHRV | Rotarix | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE-RESPONSE | DIARRHEA | EFFICACY | IGG | SERUM | IMMUNOLOGY | GASTROENTERITIS | CHILDREN | 1ST 2 YEARS | DOUBLE-BLIND | INFECTION | Infants (Newborn) | Safety regulations | Vaccination | Product development | Vaccines | Immunoglobulin A | Enzyme-linked immunosorbent assay | Health care | Neonates | Schedules | Laboratories | Clinical trials | Antibodies | Licenses | Viruses | Infants | Foaming agents | Randomization | Immunology | Safety | Drug dosages | Age | Medical research | Immunization | Disclosure | Seroconversion | Hospitals
ROTAVAC | Immunogenicity | Rotavirus vaccine | Oral vaccine | Diarrhoea | RV1 | nHRV | Rotarix | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE-RESPONSE | DIARRHEA | EFFICACY | IGG | SERUM | IMMUNOLOGY | GASTROENTERITIS | CHILDREN | 1ST 2 YEARS | DOUBLE-BLIND | INFECTION | Infants (Newborn) | Safety regulations | Vaccination | Product development | Vaccines | Immunoglobulin A | Enzyme-linked immunosorbent assay | Health care | Neonates | Schedules | Laboratories | Clinical trials | Antibodies | Licenses | Viruses | Infants | Foaming agents | Randomization | Immunology | Safety | Drug dosages | Age | Medical research | Immunization | Disclosure | Seroconversion | Hospitals
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 4, pp. 337 - 346
Rotavirus infection is a cause of considerable morbidity, with an estimated 500,000 deaths annually worldwide. This study in Vellore, India, showed that...
IMMUNITY | MEDICINE, GENERAL & INTERNAL | DIARRHEA | EFFICACY | SAFETY | VACCINE | INFANTS | DISEASE | POLYMERASE CHAIN-REACTION | COMMUNITY COHORT | CHILDREN | Recurrence | Rotavirus Infections - complications | Immunoglobulin G - blood | Humans | Diarrhea - virology | Rotavirus - immunology | Child, Preschool | Gastroenteritis - mortality | Rotavirus - genetics | Diarrhea - epidemiology | Diarrhea - prevention & control | Male | Gastroenteritis - virology | Antibodies, Viral - blood | India | Rotavirus Infections - immunology | Feces - virology | Immunoglobulin A - blood | Female | Rotavirus - isolation & purification | Infant, Newborn | Cohort Studies | Rotavirus Infections - prevention & control | Control | Statistics | Gastrointestinal diseases | Patient outcomes | Rotavirus infections | Surveillance | Gastroenteritis | Immunoglobulin G | Diarrhea | Viruses | Infections | Vaccines | Children | Immunoglobulin A | Seroconversion | Enzyme-linked immunosorbent assay | Children & youth
IMMUNITY | MEDICINE, GENERAL & INTERNAL | DIARRHEA | EFFICACY | SAFETY | VACCINE | INFANTS | DISEASE | POLYMERASE CHAIN-REACTION | COMMUNITY COHORT | CHILDREN | Recurrence | Rotavirus Infections - complications | Immunoglobulin G - blood | Humans | Diarrhea - virology | Rotavirus - immunology | Child, Preschool | Gastroenteritis - mortality | Rotavirus - genetics | Diarrhea - epidemiology | Diarrhea - prevention & control | Male | Gastroenteritis - virology | Antibodies, Viral - blood | India | Rotavirus Infections - immunology | Feces - virology | Immunoglobulin A - blood | Female | Rotavirus - isolation & purification | Infant, Newborn | Cohort Studies | Rotavirus Infections - prevention & control | Control | Statistics | Gastrointestinal diseases | Patient outcomes | Rotavirus infections | Surveillance | Gastroenteritis | Immunoglobulin G | Diarrhea | Viruses | Infections | Vaccines | Children | Immunoglobulin A | Seroconversion | Enzyme-linked immunosorbent assay | Children & youth
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 1, pp. A134 - A139
Abstract Interference from transplacental and breast milk antibodies may impede the performance of oral live vaccines. The effect of breastfeeding on the...
Allergy and Immunology | Vaccine | Immune response | Rotavirus | Rotarix | Withhold breastfeeding | Encouraged breastfeeding | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | DIARRHEA | EFFICACY | IMMUNOLOGY | GASTROENTERITIS | CHILDREN | AFRICA | IMMUNOGENICITY | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Rotarix (R) | MILK | Immunity, Maternally-Acquired | Immunoglobulin G - blood | Rotavirus Vaccines - immunology | Vaccine Potency | Humans | Immunoglobulin G - chemistry | Breast Feeding | Infant | Male | Milk, Human - chemistry | Antibodies, Viral - blood | India | Young Adult | Vaccines, Attenuated - immunology | Antibodies, Viral - chemistry | Antibody Formation | Immunoglobulin A - blood | Adult | Female | Milk, Human - immunology | Immunoglobulin A - chemistry | Rotavirus Infections - prevention & control | Infants | Vaccines | Immunoglobulin A | Breast feeding | Babies | Breastfeeding & lactation | Immune system | Children & youth | Milk | immune response | encouraged breastfeeding | rotavirus | withhold breastfeeding
Allergy and Immunology | Vaccine | Immune response | Rotavirus | Rotarix | Withhold breastfeeding | Encouraged breastfeeding | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | DIARRHEA | EFFICACY | IMMUNOLOGY | GASTROENTERITIS | CHILDREN | AFRICA | IMMUNOGENICITY | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Rotarix (R) | MILK | Immunity, Maternally-Acquired | Immunoglobulin G - blood | Rotavirus Vaccines - immunology | Vaccine Potency | Humans | Immunoglobulin G - chemistry | Breast Feeding | Infant | Male | Milk, Human - chemistry | Antibodies, Viral - blood | India | Young Adult | Vaccines, Attenuated - immunology | Antibodies, Viral - chemistry | Antibody Formation | Immunoglobulin A - blood | Adult | Female | Milk, Human - immunology | Immunoglobulin A - chemistry | Rotavirus Infections - prevention & control | Infants | Vaccines | Immunoglobulin A | Breast feeding | Babies | Breastfeeding & lactation | Immune system | Children & youth | Milk | immune response | encouraged breastfeeding | rotavirus | withhold breastfeeding
Journal Article
Vaccine, ISSN 0264-410X, 12/2018, Volume 36, Issue 51, pp. 7816 - 7819
Diarrheal disease due to Group A rotaviruses remain a leading cause of mortality and morbidity in the less developed parts of the world. India has started a...
Rotavirus epidemiology | Vellore | Tamil Nadu | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | MULTICENTER | VACCINE | CHILDREN LESS-THAN-5 YEARS | IMMUNOLOGY | GASTROENTERITIS | HOSPITALIZED CHILDREN | IMMUNIZATION | DISEASE | SURVEILLANCE | DIVERSITY | Medical research | Communicable diseases | Analysis | Mortality | Medicine, Experimental | Genetic aspects | Children | Epidemiology | Health aspects | India | Immunization | Laboratories | Diarrhea | Licenses | Viruses | Vaccines | Morbidity | Studies | Seasonal variations | Genotype & phenotype | Surveillance | Strain distribution | Age | Genotypes
Rotavirus epidemiology | Vellore | Tamil Nadu | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | MULTICENTER | VACCINE | CHILDREN LESS-THAN-5 YEARS | IMMUNOLOGY | GASTROENTERITIS | HOSPITALIZED CHILDREN | IMMUNIZATION | DISEASE | SURVEILLANCE | DIVERSITY | Medical research | Communicable diseases | Analysis | Mortality | Medicine, Experimental | Genetic aspects | Children | Epidemiology | Health aspects | India | Immunization | Laboratories | Diarrhea | Licenses | Viruses | Vaccines | Morbidity | Studies | Seasonal variations | Genotype & phenotype | Surveillance | Strain distribution | Age | Genotypes
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 1, pp. A129 - A133
Highlights • Study comparing immunogenicity of 3 and 5 doses of a monovalent oral rotavirus vaccine. • High rates (>50%) of anti-rotavirus IgA in 6 week old...
Allergy and Immunology | Immunogenicity | Rotavirus vaccine | India | MEDICINE, RESEARCH & EXPERIMENTAL | DIARRHEA | EFFICACY | SAFETY | IMMUNOLOGY | GASTROENTERITIS | CHILDREN | 1ST 2 YEARS | DOUBLE-BLIND | INFECTION | PLACEBO-CONTROLLED TRIAL | LIFE | Rotavirus Vaccines - immunology | Humans | Infant | Gastroenteritis - virology | Gastroenteritis - prevention & control | Antibodies, Viral - blood | Vaccines, Attenuated - immunology | Vaccines, Attenuated - administration & dosage | Immunoglobulin A - blood | Immunization Schedule | Rotavirus Vaccines - administration & dosage | Rotavirus Infections - prevention & control | Immunoglobulin A | Infants | Vaccines | Studies | Sample size | Diarrhea | Viruses | Infections | Developing countries--LDCs | Age
Allergy and Immunology | Immunogenicity | Rotavirus vaccine | India | MEDICINE, RESEARCH & EXPERIMENTAL | DIARRHEA | EFFICACY | SAFETY | IMMUNOLOGY | GASTROENTERITIS | CHILDREN | 1ST 2 YEARS | DOUBLE-BLIND | INFECTION | PLACEBO-CONTROLLED TRIAL | LIFE | Rotavirus Vaccines - immunology | Humans | Infant | Gastroenteritis - virology | Gastroenteritis - prevention & control | Antibodies, Viral - blood | Vaccines, Attenuated - immunology | Vaccines, Attenuated - administration & dosage | Immunoglobulin A - blood | Immunization Schedule | Rotavirus Vaccines - administration & dosage | Rotavirus Infections - prevention & control | Immunoglobulin A | Infants | Vaccines | Studies | Sample size | Diarrhea | Viruses | Infections | Developing countries--LDCs | Age
Journal Article
Vaccine, ISSN 0264-410X, 10/2017, Volume 35, Issue 45, pp. 6228 - 6237
Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing countries, resulting in enormous morbidity, mortality, and economic...
Efficacy | Infants | Vaccine | Safety | Rotavirus gastroenteritis | MEDICINE, RESEARCH & EXPERIMENTAL | FINNISH CHILDREN | INTUSSUSCEPTION | RISK | COLD-CHAIN | IMMUNOLOGY | IMMUNOGENICITY | TEMPERATURES | MONOVALENT | SCHEDULE | Severity of Illness Index | Double-Blind Method | Rotavirus Vaccines - immunology | Humans | Rotavirus - immunology | Child, Preschool | Infant | Male | Gastroenteritis - prevention & control | India | Rotavirus Infections - immunology | Reassortant Viruses - immunology | Vaccines, Attenuated - immunology | Animals | Vaccination - methods | Cattle | Female | Developing Countries | Child | Gastroenteritis - immunology | Rotavirus Infections - prevention & control | Medicine, Experimental | Clinical trials | Medical research | Product development | Vaccines | Immunization | Effectiveness | Cold | Laboratories | Gastroenteritis | Diarrhea | Licenses | Viruses | Morbidity | Developing countries--LDCs | Studies | Parents & parenting | Randomization | Poliomyelitis | Children | Age
Efficacy | Infants | Vaccine | Safety | Rotavirus gastroenteritis | MEDICINE, RESEARCH & EXPERIMENTAL | FINNISH CHILDREN | INTUSSUSCEPTION | RISK | COLD-CHAIN | IMMUNOLOGY | IMMUNOGENICITY | TEMPERATURES | MONOVALENT | SCHEDULE | Severity of Illness Index | Double-Blind Method | Rotavirus Vaccines - immunology | Humans | Rotavirus - immunology | Child, Preschool | Infant | Male | Gastroenteritis - prevention & control | India | Rotavirus Infections - immunology | Reassortant Viruses - immunology | Vaccines, Attenuated - immunology | Animals | Vaccination - methods | Cattle | Female | Developing Countries | Child | Gastroenteritis - immunology | Rotavirus Infections - prevention & control | Medicine, Experimental | Clinical trials | Medical research | Product development | Vaccines | Immunization | Effectiveness | Cold | Laboratories | Gastroenteritis | Diarrhea | Licenses | Viruses | Morbidity | Developing countries--LDCs | Studies | Parents & parenting | Randomization | Poliomyelitis | Children | Age
Journal Article
Current Opinion in Virology, ISSN 1879-6257, 08/2012, Volume 2, Issue 4, pp. 443 - 448
► Developing countries have very high rotavirus disease burden. ► Oral rotavirus vaccine trials from Africa and South Asia show low efficacy. ► Decrease in...
COST-EFFECTIVENESS | IMPACT | VIROLOGY | CHILDHOOD DIARRHEA | DISEASE BURDEN | INFANTS | HETEROTYPIC PROTECTION | INFECTION | INDIA | ECONOMIC BURDEN | VACCINES | Vaccination - economics | Rotavirus Vaccines - immunology | Developing Countries - economics | Humans | Africa | Rotavirus - immunology | Rotavirus - genetics | Rotavirus Infections - economics | Rotavirus Infections - immunology | Asia | Rotavirus Vaccines - genetics | Rotavirus Vaccines - economics | Rotavirus Infections - virology | Rotavirus Vaccines - administration & dosage | Rotavirus Infections - prevention & control
COST-EFFECTIVENESS | IMPACT | VIROLOGY | CHILDHOOD DIARRHEA | DISEASE BURDEN | INFANTS | HETEROTYPIC PROTECTION | INFECTION | INDIA | ECONOMIC BURDEN | VACCINES | Vaccination - economics | Rotavirus Vaccines - immunology | Developing Countries - economics | Humans | Africa | Rotavirus - immunology | Rotavirus - genetics | Rotavirus Infections - economics | Rotavirus Infections - immunology | Asia | Rotavirus Vaccines - genetics | Rotavirus Vaccines - economics | Rotavirus Infections - virology | Rotavirus Vaccines - administration & dosage | Rotavirus Infections - prevention & control
Journal Article
Vaccine, ISSN 0264-410X, 01/2018, Volume 36, Issue 2, pp. 273 - 279
Strategies are needed to improve oral rotavirus vaccine (RV), which provides suboptimal protection in developing countries. Probiotics and zinc supplementation...
Poliovirus vaccine | Lactobacillus GG | Rotavirus vaccines | Zinc | India | MEDICINE, RESEARCH & EXPERIMENTAL | CONTROLLED-TRIAL | DIARRHEAL HOSPITALIZATIONS | IMMUNOLOGY | CHILDREN | IMMUNOGENICITY | HEALTH IMPACT | DOUBLE-BLIND | CHOLERA VACCINE | LESS-THAN-5 YEARS | DEVELOPING-COUNTRIES | Probiotics - administration & dosage | Zinc - administration & dosage | Double-Blind Method | Rotavirus Vaccines - immunology | Administration, Oral | Humans | Infant | Male | Treatment Outcome | Antibodies, Viral - blood | Vaccines, Attenuated - immunology | Vaccines, Attenuated - administration & dosage | Immunoglobulin A - blood | Female | Lactobacillus rhamnosus - immunology | Placebos - administration & dosage | Rotavirus Vaccines - administration & dosage | Low income groups | Clinical trials | Viruses | Infections | Infants | Vaccines | Immunoglobulin A | Developing countries--LDCs | Confidence intervals | Hepatitis | Microbiota | Randomization | Intestine | Supplementation | Intestinal microflora | Age | Immune system | High income | Immune response | Urban areas | Dietary supplements | Seroconversion | Studies | Probiotics | Immunogenicity | Cholera | Factorial design
Poliovirus vaccine | Lactobacillus GG | Rotavirus vaccines | Zinc | India | MEDICINE, RESEARCH & EXPERIMENTAL | CONTROLLED-TRIAL | DIARRHEAL HOSPITALIZATIONS | IMMUNOLOGY | CHILDREN | IMMUNOGENICITY | HEALTH IMPACT | DOUBLE-BLIND | CHOLERA VACCINE | LESS-THAN-5 YEARS | DEVELOPING-COUNTRIES | Probiotics - administration & dosage | Zinc - administration & dosage | Double-Blind Method | Rotavirus Vaccines - immunology | Administration, Oral | Humans | Infant | Male | Treatment Outcome | Antibodies, Viral - blood | Vaccines, Attenuated - immunology | Vaccines, Attenuated - administration & dosage | Immunoglobulin A - blood | Female | Lactobacillus rhamnosus - immunology | Placebos - administration & dosage | Rotavirus Vaccines - administration & dosage | Low income groups | Clinical trials | Viruses | Infections | Infants | Vaccines | Immunoglobulin A | Developing countries--LDCs | Confidence intervals | Hepatitis | Microbiota | Randomization | Intestine | Supplementation | Intestinal microflora | Age | Immune system | High income | Immune response | Urban areas | Dietary supplements | Seroconversion | Studies | Probiotics | Immunogenicity | Cholera | Factorial design
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 1, pp. A10 - A12
Highlights • Rotavirus is a major cause of hospitalizations due to diarrhea in children <5 years of age. • G1P[8] and G2P[4] are the most commonly isolated...
Allergy and Immunology | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOGENICITY | GENOTYPE | SAFETY | DISEASE | VACCINATION | IMMUNOLOGY | Prevalence | Rotavirus Infections - epidemiology | Humans | Diarrhea - virology | Child, Preschool | Cost of Illness | India - epidemiology | Rotavirus - genetics | Diarrhea - epidemiology | Genotype | Infant | Male | Hospitalization | Molecular Epidemiology | Female | Seasons | Population Surveillance | Diarrhea | Hospital patients | Studies | Antigens | Hospitals | Testing laboratories | Viruses | Vaccines | Epidemiology | Age | Children & youth | Shipments
Allergy and Immunology | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOGENICITY | GENOTYPE | SAFETY | DISEASE | VACCINATION | IMMUNOLOGY | Prevalence | Rotavirus Infections - epidemiology | Humans | Diarrhea - virology | Child, Preschool | Cost of Illness | India - epidemiology | Rotavirus - genetics | Diarrhea - epidemiology | Genotype | Infant | Male | Hospitalization | Molecular Epidemiology | Female | Seasons | Population Surveillance | Diarrhea | Hospital patients | Studies | Antigens | Hospitals | Testing laboratories | Viruses | Vaccines | Epidemiology | Age | Children & youth | Shipments
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 1, pp. A84 - A88
Highlights • A strategy for rotavirus genotyping and resolution of untypable samples for surveillance program is defined. • Untypability of samples may be due...
Allergy and Immunology | ELISA false positive | Specific priming | Untyped Protocol | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | SOUTH-INDIA | DIVERSITY | CHILDREN YOUNGER | IMMUNOLOGY | HOSPITAL-BASED SURVEILLANCE | Gastroenteritis - epidemiology | Rotavirus Infections - epidemiology | Humans | India - epidemiology | Rotavirus - genetics | Antigens, Viral - genetics | Genotype | Gastroenteritis - virology | Sequence Analysis, DNA | Molecular Epidemiology | Rotavirus Infections - virology | Population Surveillance | Capsid Proteins - genetics | Enzymes | Chemical properties | Polymerase chain reaction | Diarrhea | Viruses | Methods
Allergy and Immunology | ELISA false positive | Specific priming | Untyped Protocol | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | SOUTH-INDIA | DIVERSITY | CHILDREN YOUNGER | IMMUNOLOGY | HOSPITAL-BASED SURVEILLANCE | Gastroenteritis - epidemiology | Rotavirus Infections - epidemiology | Humans | India - epidemiology | Rotavirus - genetics | Antigens, Viral - genetics | Genotype | Gastroenteritis - virology | Sequence Analysis, DNA | Molecular Epidemiology | Rotavirus Infections - virology | Population Surveillance | Capsid Proteins - genetics | Enzymes | Chemical properties | Polymerase chain reaction | Diarrhea | Viruses | Methods
Journal Article